Asia-Pacific in the Eye of AMR Storm

  31 May 2021

Antimicrobial resistance (AMR) is a growing threat with clinical, societal and economic impact to the entire Asia-Pacific (APAC) region. The World Bank forecasts that APAC will account for 47% of the AMR-related deaths worldwide, due to a confluence of factors including: high resistance rates, insufficient infrastructure and challenges to the affordability of managing AMR.

In this Special Report, we examine current efforts in the region to combat AMR and identify the challenges undercutting the full impact of these initiatives in Asia. We explore innovative solutions in AMR diagnostics, research and development (R&D), and commercialization that can jumpstart programs in the space, provide health and socio-economic value to APAC nations and ultimately reverse the rising AMR trend.

Further reading: LEK
Author(s): Jonathan Kfoury, Fabio La Mola, Mei Young, Samyukta Ravishankar
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

More information

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed